NanoViricides Inc. (NNVC)

[Ubertino]

Ebola ‘Transmission Dynamics’

Columbia University researchers predicted 18,755 cases by Oct. 26 if the situation didn’t change, and 49,129 if intervention and containment efforts degraded.

“Our understanding of Ebola transmission dynamics is incomplete and data on the present outbreak are limited,” the researchers said.

Curbing the outbreak will require investments of $988 million over the next six months, according to an overview of needs and requirements published by the UN. About 30 percent of what’s needed has come in so far, Nabarro said this week at a briefing in Geneva.

There is no cure for Ebola, which is spread by contact with the blood and bodily fluids of those infected. The disease normally is treated by keeping patients hydrated, replacing lost blood and using antibiotics to fight infections. The hope is that a patient’s immune system will fight off the aggressive attack of the virus.

Several companies and government health authorities are testing experimental treatments and vaccines against the disease. The most notable and effective being NanoViricides (NNVC) now producing and testing EbolaCide2 with the aid and assistance of USAMRIID and NIH.

http://www.bloomberg.com/news/2014-09-19/ebola-worst-case-scenario-has-more-than-500-000-cases.html

Mine